Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) Partners with Siemens Healthineers to License DxA's SpeechDx Dataset, Gold-Standard Dataset for Alzheimer's Speech Biomarkers ...

Siemens is the first of many partners to non-exclusively license SpeechDx's speech and clinical dataset with the goal of developing a speech-based biomarker for Alzheimer's disease. NEW YORK, May ...

Siemens is the first of many partners to non-exclusively license SpeechDx's speech and clinical dataset with the goal of developing a speech-based biomarker for Alzheimer's disease. NEW YORK, May ...

Siemens is the first of many partners to non-exclusively license SpeechDx's speech and clinical dataset with the goal of developing a speech-based biomarker for Alzheimer's disease. NEW YORK, May ...

Siemens is the first of many partners to non-exclusively license SpeechDx's speech and clinical dataset with the goal of developing a speech-based biomarker for Alzheimer's disease. NEW YORK, May ...